financetom
Business
financetom
/
Business
/
First Solar Insider Sold Shares Worth $1,913,418, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Solar Insider Sold Shares Worth $1,913,418, According to a Recent SEC Filing
Aug 14, 2024 3:29 PM

06:02 PM EDT, 08/14/2024 (MT Newswires) -- Patrick James Buehler, Chief Product Officer, on August 13, 2024, sold 8,619 shares in First Solar ( FSLR ) for $1,913,418. Following the Form 4 filing with the SEC, Buehler has control over a total of 3,468 shares of the company, with 3,468 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1274494/000112760224022209/xslF345X03/form4.xml

Price: 226.25, Change: +0.71, Percent Change: +0.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wayfair Q2 Adjusted Earnings Increase While Net Revenue Decreases
Wayfair Q2 Adjusted Earnings Increase While Net Revenue Decreases
Aug 1, 2024
09:24 AM EDT, 08/01/2024 (MT Newswires) -- Wayfair ( W ) reported Q2 adjusted earnings Thursday of $0.47 per diluted share, up from $0.21 a year earlier. That result matched the average estimate of analysts polled by Capital IQ. Net revenue for the quarter ended June 30 was $3.12 billion, down from $3.17 billion a year earlier. Analysts surveyed by...
Medicenna Reports First
Medicenna Reports First "Complete Responder" With MDNA11 Monotherapy, Q1 Results
Aug 1, 2024
09:23 AM EDT, 08/01/2024 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) on Thursday reported the latest patient data from its MDNA11 monotherapy program and its first-quarter results. The company said a patient with melanoma achieved a complete response following treatment with MDNA11 at week 52. The patient, which had failed previous therapy, showed 100% regression of all target and...
Increased Energy Consumption Boosts Southern Company's Q2 Performance: Details
Increased Energy Consumption Boosts Southern Company's Q2 Performance: Details
Aug 1, 2024
Southern Company ( SO ) shares are trading lower after the company reported a second-quarter 2024 operating revenue rose 12.4% Y/Y to $6.463 billion, beating the consensus of $6.099 billion.  Operating revenues by segment: Alabama Power $1.873 billion (+10.9% Y/Y), Georgia Power $2.875 billion (+20.2% Y/Y), Mississippi Power $364 million (+17.0% Y/Y), Southern Power $524 million (-0.2% Y/Y) and Southern Company Gas $831 million (-2.5% Y/Y). Total Regulated Utility Customers increased 0.8% Y/Y, with Total Traditional Electric +1.2% and Southern Company Gas +0.4%. Kilowatt-Hour Sales rose by 3.9% Y/Y, with...
Blueprint Medicines Q2 Loss Narrows, Revenue Rises
Blueprint Medicines Q2 Loss Narrows, Revenue Rises
Aug 1, 2024
09:23 AM EDT, 08/01/2024 (MT Newswires) -- Blueprint Medicines ( BPMC ) reported a Q2 net loss Thursday of $0.80 per diluted share, narrower than a loss of $2.19 a year earlier. Analysts polled by Capital IQ expected a loss of $1.29. Revenue for the quarter ended June 30 was $138.2 million, up from $57.6 million a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved